Literature DB >> 29654380

Heart rate variability and baroreflex sensitivity abnormalities in Guillain-Barré syndrome: a pilot study.

Cheng-Yin Tan1, Nortina Shahrizaila2, Kee-Ying Yeoh2, Khean-Jin Goh2, Maw-Pin Tan3.   

Abstract

OBJECTIVE: The current study aimed to investigate autonomic dysfunction in Guillain-Barré syndrome (GBS) patients and describe the results of computational heart rate variability (HRV)/baroreflex sensitivity (BRS) and autonomic challenge tests.
METHODS: GBS patients were consecutively recruited and the results were compared to age- and gender-matched healthy controls. A series of autonomic function tests including computation-dependent tests (power spectrum analysis of HRV and BRS at rest) and challenge maneuvers (deep breathing, eyeball compression, active standing, the Valsalva maneuver, sustained handgrip, and the cold pressor test) were performed.
RESULTS: Ten GBS patients (six men; mean age = 40.1 ± 13.9 years) and ten gender- and age-matched healthy controls were recruited. The mean GBS functional grading scale at disease plateau was 3.4 ± 1.0. No patients required intensive care unit admission or mechanical ventilation. Low-frequency HRV (p = 0.027), high-frequency HRV (p = 0.008), and the total power spectral density of HRV (p = 0.015) were significantly reduced in patients compared to controls. The mean up slope (p = 0.034), down slope (p = 0.011), and total slope (p = 0.024) BRS were significantly lower in GBS patients. The diastolic rise in blood pressure in the cold pressor test was significantly lower in GBS patients compared to controls (p = 0.008).
INTERPRETATION: Computation-dependent tests (HRV and BRS) were more useful for detecting autonomic dysfunction in GBS patients, whereas the cold pressor test was the only reliable challenge test, making it useful as a bedside measure of autonomic function in GBS patients.

Entities:  

Keywords:  Autonomic dysfunction; Autonomic function test; Baroreflex sensitivity; Guillain–Barré syndrome; Heart rate variability

Mesh:

Year:  2018        PMID: 29654380     DOI: 10.1007/s10286-018-0525-z

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  40 in total

1.  Guillain-Barré syndrome: incidence and mortality rates in US hospitals.

Authors:  Amer Alshekhlee; Zulfiqar Hussain; Badr Sultan; Bashar Katirji
Journal:  Neurology       Date:  2008-04-29       Impact factor: 9.910

2.  High mortality from Guillain-Barré syndrome in Bangladesh.

Authors:  Tanveen Ishaque; Mohammad B Islam; Gulshan Ara; Hubert P Endtz; Quazi D Mohammad; Bart C Jacobs; Zhahirul Islam
Journal:  J Peripher Nerv Syst       Date:  2017-06       Impact factor: 3.494

3.  Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans.

Authors:  G Parati; M Di Rienzo; G Bertinieri; G Pomidossi; R Casadei; A Groppelli; A Pedotti; A Zanchetti; G Mancia
Journal:  Hypertension       Date:  1988-08       Impact factor: 10.190

Review 4.  Diagnosis and management of diabetic autonomic neuropathy.

Authors:  D J Ewing; B F Clarke
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-02

5.  Fatal Guillain-Barré syndrome.

Authors:  N D Lawn; E F Wijdicks
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

6.  The value of comparing mortality of Guillain-Barré syndrome across different regions.

Authors:  A H Y Wong; T Umapathi; N Shahrizaila; Y C Chan; N Kokubun; M K Fong; Y P Chu; P K Lau; N Yuki
Journal:  J Neurol Sci       Date:  2014-06-19       Impact factor: 3.181

7.  Sympathetic skin response in Guillain-Barré syndrome.

Authors:  A B Taly; G R Arunodaya; S Rao
Journal:  Clin Auton Res       Date:  1995-09       Impact factor: 4.435

Review 8.  Autonomic involvement in Guillain-Barré syndrome: a review.

Authors:  D W Zochodne
Journal:  Muscle Nerve       Date:  1994-10       Impact factor: 3.217

9.  Inpatient management of guillain-barré syndrome.

Authors:  Matthew Harms
Journal:  Neurohospitalist       Date:  2011-04

10.  Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.

Authors:  R D Hadden; D R Cornblath; R A Hughes; J Zielasek; H P Hartung; K V Toyka; A V Swan
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.